Astellas In Multinational Deal To Develop, Market Global Vaccines
This article was originally published in PharmAsia News
Executive Summary
Astellas Pharma disclosed it has formed a partnership with Swiss-based ClearPath Development and launched RSV Corp. to develop and market vaccines on a global basis.